The Vascular Care Group Enrolls Nation's First Patient in FORTAVENA Post-Market Study
prlog.org
The Vascular Care Group (TVCG) announced that its Darien, Connecticut vascular center has enrolled the first patient in the nation in the FORTAVENA Post-Market Study, formally titled "The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study." The...



COMENTÁRIOS